We are talking about antibacterial drugs based on levonadifloxacin with a broad spectrum of action representing new chemical compounds (HCCs) for the treatment of various bacterial infections, as well as skin and skin structures, including foot infections in diabetes and concomitant bacteremia.
According to the company, the drugs will target such superbugs as methicillin-resistant Staphylococcus aureus (MRSA), which is the main reason for the growth of antimicrobial resistance (AMR).
"Due to the broad spectrum of action against common pathogens, including MRSA, higher safety compared to currently available anti-MRSA drugs, I believe that these drugs have great potential to effectively meet the medical needs of healthcare professionals, thereby helping to reduce complications and mortality.",
— said the founder of the Wockhardt Group Habil Horakiwala.
Under the terms of the agreement, Wockhardt Bio AG retains ownership of the above-mentioned antibiotics, and local registration clinical trials, registration, marketing and commercial promotion in the institutional markets of the EAEU will be carried out exclusively by the company "GPHC".
Information from the company:
Wockhardt is a global pharmaceutical and biotechnology organization, headquartered in Mumbai (India). The company has 3 research centers and 12 manufacturing enterprises engaged in the production and marketing of pharmaceutical and biopharmaceutical formulations, active pharmaceutical ingredients and vaccines that meet the requirements of the FDA (USA), MHRA (UK) and EMEA (European Union).
GPHC is a Russian pharmaceutical company that systematically implements its long—term development strategy aimed at the development, production, registration, marketing and promotion of its own medicines, along with the registration, development and promotion of original medicines of domestic and foreign partners.
The structure and purpose of the GPHC business is based on increasing the availability of necessary medicines in order to shorten the recovery time of patients.
Source: Farmvestnik.
